Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05235321 · ClinicalTrials.gov registry record · NA

Automated Applanation Tonometry

A NA study, sponsored by Duke University.

Terminated
Registry status
NA
Development phase
111
Enrollment target

NCT05235321 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 111 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05235321, a NA study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
NA
Development phase
111 participants
Enrollment target

Study Summary

Goldmann Applanation Tonometry (GAT) is considered the clinical gold standard for eye pressure measurements and yet it is known to be a subjective measurement with limited repeatability and limited portability. The purpose of this study is to develop an automated and objective method for performing applanation tonometry using standard ophthalmic equipment as well as using 2 portable prototypes.

Interventions

  • DEVICE Standard GAT
  • DEVICE Fixed force GAT
  • DEVICE Upright applanating prototype
  • DEVICE Supine Applanating Prototype

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2022-11-21
Est. Completion 2024-05-31
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05235321

The ClinicalTrials.gov registry entry for NCT05235321 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Standard GAT is the first listed.

NCT05235321 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05235321 about?

NCT05235321 is a clinical study titled "Automated Applanation Tonometry". Goldmann Applanation Tonometry (GAT) is considered the clinical gold standard for eye pressure measurements and yet it is known to be a subjective measurement with limited repeatability and limited portability. The purpose of this study is to develop an automated and objective method for performing ...

What is the current status of trial NCT05235321?

This trial is currently terminated. It is a NA study. The enrollment target is 111 participants. The study started on 2022-11-21. Estimated completion is 2024-05-31.

What interventions are being tested in trial NCT05235321?

The interventions under investigation include: Standard GAT (DEVICE), Fixed force GAT (DEVICE), Upright applanating prototype (DEVICE), Supine Applanating Prototype (DEVICE).

Who is sponsoring clinical trial NCT05235321?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.